Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis
AuthorsCarrol, Enitan D
Pepper, Stuart D
Saunders, Emma K
Mankhambo, Limangeni A
Ollier, William E
Hart, C Anthony
AffiliationMalawi-Liverpool-Wellcome Trust Clinical Research Programme, PO Box 30096, Blantyre, Malawi, Africa. firstname.lastname@example.org
MetadataShow full item record
AbstractBACKGROUND: The challenge of gene expression studies is to reliably quantify levels of transcripts, but this is hindered by a number of factors including sample availability, handling and storage. The PAXgene Blood RNA System includes a stabilizing additive in a plastic evacuated tube, but requires 2.5 mL blood, which makes routine implementation impractical for paediatric use.The aim of this study was to modify the PAXgene Blood RNA System kit protocol for application to small, sick children, without compromising RNA integrity, and subsequently to perform quantitative analysis of ICAM and interleukin-6 gene expression.Aliquots of 0.86 mL PAXgene reagent were put into microtubes and 0.3 mL whole blood added to maintain the same recommended proportions as in the PAXgene evacuated tube system. RNA quality was assessed using the Agilent BioAnalyser 2100 and an in-house TaqMan assay which measures GAPDH transcript integrity by determining 3' to 5' ratios. qPCR analysis was performed on an additional panel of 7 housekeeping genes. Three reference genes (HPRT1, YWHAZ and GAPDH) were identified using the GeNORM algorithm, which were subsequently used to normalising target gene expression levels. ICAM-1 and IL-6 gene expression were measured in 87 Malawian children with invasive pneumococcal disease. RESULTS: Total RNA yield was between 1,114 and 2,950 ng and the BioAnalyser 2100 demonstrated discernible 18s and 28s bands. The cycle threshold values obtained for the seven housekeeping genes were between 15 and 30 and showed good consistency. Median relative ICAM and IL-6 gene expression were significantly reduced in non-survivors compared to survivors (ICAM: 3.56 vs 4.41, p = 0.04, and IL-6: 2.16 vs 6.73, p = 0.02). CONCLUSION: We have successfully modified the PAXgene blood collection system for use in small children and demonstrated preservation of RNA integrity and successful quantitative real-time PCR analysis.
CitationSuccessful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. 2007, 8:20 BMC Immunol.
- Preanalytical robustness of blood collection tubes with RNA stabilizers.
- Authors: Stellino C, Hamot G, Bellora C, Trouet J, Betsou F
- Issue date: 2019 Sep 25
- Examination of stability of bone marrow blood RNA in the PAXgene tube.
- Authors: Yamamoto T, Sekiyama A, Sekiguchi H, Yoshida T, Miyagi Y
- Issue date: 2006
- Recovery of microarray-quality RNA from frozen EDTA blood samples.
- Authors: Beekman JM, Reischl J, Henderson D, Bauer D, Ternes R, Peña C, Lathia C, Heubach JF
- Issue date: 2009 Jan-Feb
- Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples.
- Authors: Chai V, Vassilakos A, Lee Y, Wright JA, Young AH
- Issue date: 2005
- Gene expression differences between PAXgene and Tempus blood RNA tubes are highly reproducible between independent samples and biobanks.
- Authors: Skogholt AH, Ryeng E, Erlandsen SE, Skorpen F, Schønberg SA, Sætrom P
- Issue date: 2017 Mar 23